Growth factor sustained-release microsphere and preparation method thereof
A growth factor and slow-release microsphere technology, applied in the field of medicine, can solve the problems of ineffectiveness, short half-life, protease hydrolysis, etc., and achieve the effects of reducing the occurrence of cytotoxicity, maintaining activity, and enhancing the slow-release ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] An embodiment of the growth factor slow-release microspheres of the present invention, the growth factor slow-release microspheres of the present embodiment include the following components by weight:
[0033] (a) 3 parts of sulfonated chitosan, 4 parts of heparin, 0.005 part of growth factor, 8 parts of polyamino acid, 5 parts of polyanhydride, 7 parts of thickener, and 5 parts of insoluble polymer carrier;
[0034] (b) 3.5 parts of natural crosslinking agent.
[0035] Wherein, the growth factor is TGF-β1, the thickener is carboxymethyl cellulose, the insoluble polymer carrier is polylactic acid-glycolic acid copolymer, and the natural crosslinking agent is tannic acid .
[0036] The preparation method of the growth factor sustained-release microspheres of the present embodiment is:
[0037] 1) Dissolve 3 mg of sulfonated chitosan and 4 mg of heparin in 10 mL of purified water to obtain mixed solution A, then add 5 μg of TGF-β1 growth factor to mixed solution A and m...
Embodiment 2
[0044] An embodiment of the growth factor slow-release microspheres of the present invention, the growth factor slow-release microspheres of the present embodiment include the following components by weight:
[0045] (a) 2 parts of sulfonated chitosan, 1 part of heparin, 0.001 part of growth factor, 1 part of polyamino acid, 3 parts of polyanhydride, 1 part of thickener, and 4 parts of insoluble polymer carrier;
[0046] (b) 2 parts of natural crosslinking agent.
[0047] Wherein, the growth factor is TGF-β1, the thickener is carboxymethyl cellulose, the insoluble polymer carrier is polylactic acid-glycolic acid copolymer, and the natural crosslinking agent is tannic acid .
[0048] The preparation method of the growth factor sustained-release microspheres of the present embodiment is:
[0049] 1) Dissolve 2 mg of sulfonated chitosan and 1 mg of heparin in 10 mL of purified water to obtain mixed solution A, then add 1 μg of TGF-β1 growth factor to mixed solution A and mix to...
Embodiment 3
[0056] An embodiment of the growth factor slow-release microspheres of the present invention, the growth factor slow-release microspheres of the present embodiment include the following components by weight:
[0057] (a) 5 parts of sulfonated chitosan, 6 parts of heparin, 0.01 part of growth factor, 15 parts of polyamino acid, 10 parts of polyanhydride, 10 parts of thickener, and 9 parts of insoluble polymer carrier;
[0058] (b) 5 parts of natural crosslinking agent.
[0059] Wherein, the growth factor is TGF-β1, the thickener is carboxymethyl cellulose, the insoluble polymer carrier is polylactic acid-glycolic acid copolymer, and the natural crosslinking agent is tannic acid .
[0060] The preparation method of the growth factor sustained-release microspheres of the present embodiment is:
[0061] 1) Dissolve 5 mg of sulfonated chitosan and 6 mg of heparin in 10 mL of purified water to obtain a mixed solution A, then add 10 μg of TGF-β1 growth factor to the mixed solution ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com